Propecia, Proscar 3rd Q/YTD sales

Propecia 3rd Q sales are down 7% from the 3rd Q of 2011-- 104 million to 112 million
Propecia YTD sales are down 5% from 312 million in 2012-- 330 million in 2011

Proscar 3rd Q sales are down 6% from the 3rd Q of 2011–55 million to 58 million
Proscar YTD sales are down 6% from 2011 160 million in 2012–171 million in 2011

mercknewsroom.com/press-rele … al-results

Nice!! Hopefully with more driven media awareness this will continue to decline! 6-7% is an enormous decline for sales.

I would think it’d be more than that. Shouldn’t physicians be warning their patients who are taking it about the consequences? Shouldn’t they try to taper them off of it?

With the new side effects added to the label a doctor would have to be an idiot to give this stuff out to people for BPH let alone simple hairloss.

Well, we unfortunately know all too well there’s plenty such doctors.